Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enkurin domain containing 1 (ENKD1)
- Target
- ENKD1
- Molecular classification
- Microtubule-associated protein (MAP), Centrosomal and ciliary protein, Intracellular cytoskeletal protein
01
Overview
Enkurin domain containing 1 (ENKD1) is a microtubule-associated protein found in the cytoskeleton at centrosomes and cilia. It binds alpha-tubulin and plays pivotal roles in organizing microtubule-based structures, stabilizing microtubules, promoting proper mitotic spindle orientation during cell division, and enabling the assembly of non-motile (primary) cilia and the regulation of ciliary signaling. ENKD1 facilitates ciliogenesis by promoting the removal of CP110 from the mother centriole through competitive interaction, antagonizing CEP97. This is crucial for initiating cilium formation and impacts developmental processes such as left–right asymmetry. Dysregulation of ENKD1 has been associated with impaired asymmetric division in keratinocytes, defective epidermal layer stratification, and reduced ciliary signaling. Lower ENKD1 expression or gene fusion events have been implicated in cancer progression (notably non-small cell lung cancer and T-cell acute lymphoblastic leukemia), making ENKD1 a candidate biomarker and possible drug target.
- Other names
- ENKD1C16orf48DAKV6410
02
Mechanism of action
null
03
Biological functions
Microtubule organization and stabilizationPromotion of astral microtubule stability and proper spindle orientation during mitosisRegulation of cilium assembly and ciliogenesisCell signaling, especially in ciliary signaling pathwaysRegulation of cell proliferation, migration, and invasionRegulation of asymmetric cell division and epidermal stratification
04
Disease associations
Cancer (especially non-small cell lung cancer and T-cell acute lymphoblastic leukemia)Developmental disorders (via functions in cilia and centrosome; ciliary dysfunction associated with developmental disease)Other (general disruption of microtubule/ciliary function can lead to diseases linked to cell division and differentiation)
05
Safety considerations
No notable safety or therapeutic challenges have been reported specifically for ENKD1 targeting; however, as a regulator of spindle orientation and cilium formation, off-target effects could potentially affect cell division or development
06
Biomarkers
Reduced expression of ENKD1 may serve as a biomarker for non-small cell lung cancerAltered function or fusion of ENKD1 may constitute a biomarker in T-cell acute lymphoblastic leukemia
Beyond the preview
Go deeper on Enkurin domain containing 1 (ENKD1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enkurin domain containing 1 (ENKD1).